• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    Galectin Therapeutics, Inc. (GALT)

    -NasdaqCM
    2.57 Up 0.03(1.18%) Jul 31, 4:00PM EDT
    Add to Portfolio
    Insider RosterGet Insider Roster for:
    Insider Holders*
    Individual/EntityMost Recent Trans.Shares Owned as of Trans. Date
    10X FUND, L.P.
    Beneficial Owner (10% or more)
    Option Exercise
    Jan 27, 2014
    2,776,186
    Jan 27, 2014
    AMELIO GILBERT F
    Director
    Acquisition (Non Open Market)
    Apr 8, 2015
    120,061
    Apr 8, 2015
    CALLICUTT JACK W
    Officer
    Purchase
    Aug 14, 2014
    1,260
    Aug 14, 2014
    CZIRR JAMES C
    Officer
    Disposition (Non Open Market)
    Jan 31, 2015
    3,839,048
    Jan 31, 2015
    FREEMAN KEVIN D
    Director
    Purchase
    Jun 1, 2015
    29,726
    Jun 1, 2015
    GREENBERG ARTHUR
    Director
    Acquisition (Non Open Market)
    Mar 12, 2015
    107,779
    Mar 12, 2015
    MARTIN ROD D
    Director
    Acquisition (Non Open Market)
    Apr 8, 2015
    2,978,275
    Apr 8, 2015
    MAULDIN JOHN F
    Director
    Acquisition (Non Open Market)
    Apr 8, 2015
    42,669
    Apr 8, 2015
    OMENN GILBERT S
    Director
    Acquisition (Non Open Market)
    Apr 8, 2015
    67,561
    Apr 8, 2015
    PRELACK STEVEN
    Director
    Acquisition (Non Open Market)
    Apr 8, 2015
    107,189
    Apr 8, 2015
    PRESSLER HERMAN PAUL
    Director
    Acquisition (Non Open Market)
    Apr 8, 2015
    36,767
    Apr 8, 2015
    RUBIN MARC
    Director
    Acquisition (Non Open Market)
    May 21, 2015
    48,581
    May 21, 2015
    SHLEVIN HAROLD H.
    Officer
    Disposition (Non Open Market)
    Apr 16, 2014
    53,914
    Apr 16, 2014
    TRABER PETER G
    Officer
    Purchase
    Jun 1, 2015
    105,333
    Jun 1, 2015

    View Transactions for Insiders & Institutional Holders

     
    * Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.